Literature DB >> 14984935

GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma?

Carien L Creutzberg.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 14984935     DOI: 10.1016/j.ygyno.2004.01.009

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  9 in total

Review 1.  Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions?

Authors:  S Marnitz; C Köhler; N Gharbi; S Kunze; K Jablonska; J Herter
Journal:  Strahlenther Onkol       Date:  2018-08-15       Impact factor: 3.621

2.  Recurrence and survival in surgically treated endometrioid endometrial cancer.

Authors:  Alex Sanjuán; Teresa Cobo; Georgia Escaramís; Angels Rovirosa; Jaume Ordi; Sonia García; Sandra Hernández; Xavier Caparrós; Aureli Torné; Sergio Martínez Román; Juan Antonio Lejárcegui; Jaume Pahisa
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

3.  Major clinical research advances in gynecologic cancer 2008.

Authors:  Kidong Kim; Seok-Cheol Choi; Sang-Young Ryu; Jae Weon Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2008-12-29       Impact factor: 4.401

4.  Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.

Authors:  Andrea Mariani; Sean C Dowdy; William A Cliby; Bobbie S Gostout; Monica B Jones; Timothy O Wilson; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2008-03-04       Impact factor: 5.482

5.  External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: clinical outcomes and toxicity rates.

Authors:  V De Sanctis; L Agolli; M Valeriani; S Narici; M F Osti; F Patacchiola; B Mossa; M Moscarini; R Maurizi Enrici
Journal:  Radiol Med       Date:  2012-05-14       Impact factor: 3.469

6.  Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer.

Authors:  Manon Daix; Martina Aida Angeles; Federico Migliorelli; Athanasios Kakkos; Carlos Martinez Gomez; Katty Delbecque; Eliane Mery; Stéphanie Tock; Erwan Gabiache; Marjolein Decuypere; Frédéric Goffin; Alejandra Martinez; Gwénaël Ferron; Frédéric Kridelka
Journal:  J Gynecol Oncol       Date:  2021-04-05       Impact factor: 4.401

Review 7.  Endometrial cancer - reduce to the minimum. A new paradigm for adjuvant treatments?

Authors:  Heike R Scheithauer; Diana S Schulz; Claus Belka
Journal:  Radiat Oncol       Date:  2011-11-25       Impact factor: 3.481

8.  Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial.

Authors:  R Maggi; A Lissoni; F Spina; M Melpignano; P Zola; G Favalli; A Colombo; R Fossati
Journal:  Br J Cancer       Date:  2006-07-25       Impact factor: 7.640

9.  Adjuvant Pelvic Radiotherapy vs. Sequential Chemoradiotherapy for High-Risk Stage I-II Endometrial Carcinoma.

Authors:  Hend Ahmed El-Hadaad; Hanan Ahmed Wahba; Anas Mohamed Gamal; Tamer Dawod
Journal:  Cancer Biol Med       Date:  2012-09       Impact factor: 4.248

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.